May
31
Main Street Family Pharmacy LLC has announced a voluntary recall of one of its pharmaceutical products. The product, an injectable anti-inflammatory drug, has been linked to seven cases of adverse events in the form of skin abscesses, one of which, the FDA reports, appears to be fungal in nature. Although the investigation into the exact source […]
May
27
GranuFlo®, along with Naturalyte®, is a component of dialysis solution used in cleaning a patient’s blood during dialysis treatment. The drug has been linked to a number of harmful side effects and injuries, including stroke, cardiac arrhythmia, and cardiac arrest. Such dangers led to a Class I Recall of the drug in 2012. As the […]
May
26
According to a recent report, research suggests that Zoloft®, a commonly prescribed selective serotonin reuptake inhibitor (SSRI), may lead to surgical complications. A study conducted by Dr. Andrew Auerbach and his team revealed that patients taking Zoloft® and other SSRIs were more likely to be readmitted to the hospital within a month of surgery. The […]
May
25
This month, two new studies evaluate the dangers of intracranial Pradaxa® brain hemorrhage among patients with closed head injuries. In the Journal of Neurosurgery report, researchers compared case studies among head trauma patients on Warfarin®, an older blood thinner, with patients on Pradaxa® and others who took no anticoagulants. The study included fifteen patients who […]
May
24
According to a report about the first Actos® lawsuit to go to trial in California, Dr. Norm Smith, a professor at the University of Chicago Medical Center, testified about the medical effects of Jack Cooper’s ingestion of Actos®. In particular, the doctor noted that Mr. Cooper had a history of cigarette smoking, including a bout […]
May
23
According to California court documents released in April, an internal evaluation by Johnson & Johnson found that nearly 40 percent of patients with a DePuy ASR™ (Articular Surface Replacement) hip system would experience total failure within five years. Most prosthetic hips, however, are engineered to last up to fifteen years, with hip replacement rates after […]
May
22
On March 29, 2013, the Judicial Panel on Multidistrict Litigation (JPML) announced that all NaturaLyte® and GranuFlo® federal lawsuits will be consolidated for pre-trial proceedings in the Northern District of Massachusetts. Fresenius Medical Care, the manufacturer of NaturaLyte® and GranuFlo®, began selling the dialysates in 2003, when they first received FDA approval. Both are engineered […]
May
21
According to a news update, Boehringer Ingelheim, the manufacturer of the anticoagulant Pradaxa®, is the target of a lawsuit over allegations that the drug leads to severe internal bleeding. One of the plaintiffs in this lawsuit – which is now part of the Pradaxa® MDL pending in the Southern District of Illinois – Robert Connelly, […]
May
20
On April 13, 2013, the Consumers’ Union sent a letter to the FDA urging it to adopt a rule that would require the agency’s premarket approval (PMA) to review high risk implants in order to determine their safety. According to the letter, which was signed by more than 11,000 people, current loopholes in the law […]
May
14
There are currently over 2,000 Actos bladder cancer claims on file against Takeda Pharmaceuticals in Cook County Circuit Court in Chicago, Illinois. As of now, the first trials for the Cook County consolidated litigation are scheduled to commence in Chicago within the next year. Actos® is a medication prescribed to control glucose (blood sugar) in […]
Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.
The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.
We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.
Copyright © 2013 Schlichter Bogard & Denton